Hypothyroxinemia in the preterm infant: The benefits and risks of thyroxine treatment

Journal of Pediatrics

Volumn 139, Issue 2, 2001, Pages 182-188

  Rapaport, Robert ^a,b,c   Rose, Susan R ^a,b,c   Freemark, Michael ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUCOCORTICOID; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG EFFECT; FETUS; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROTROPINEMIA; HYPOTHYROIDISM; HYPOTHYROXINEMIA; INFANT; MORBIDITY; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0034896532     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.116934     Document Type: Article

References (52)

1. Thyroid function in premature infants
2. Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
3. Thyroid function in the preterm infant
4. 5′-Mono-deiodinase activity in developing human cerebral cortex
5. Ontogeny of iodothyronine deiodinases in human liver
6. Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis
7. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy
8. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism
9. Early effects of iodine deficiency on radial glial cells of the hippocampus of the rat fetus. A model of neurological cretinism
10. Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3′ tri-iodothyronine in the protection of the fetal brain
11. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency
12. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid agenesis
13. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
14. Thyroid function in very preterm infants: Influences of gestational age and disease
15. Serum free thyroxine and free triiodothyroinine concentrations in healthy fullterm, preterm and sick preterm neonates
16. Maturation of feedback control of thyrotropin in premature infants
17. Absence of athyreosis in congenital hypothyroidism (CH): Results of improved thyroid imaging
18. Thyrotropin-releasing hormone stimulation tests in infants
19. Thyroid function in very low birth weight infants: Effects on neonatal hypothyroid screening
20. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants
21. Neonatal hypothyroxinemia: Effects of iodine intake and premature birth
22. Dopamine suppresses thyroid stimulating hormone secretion in neonatal hypothyroidism
23. Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: A clinical research center study
24. Serum free thyroxine concentration is not reduced in premature infants with respiratory distress syndrome
25. Thyroxine screening values in premature infants
26. Thyroid function in premature infants
27. Reference ranges for newer thyroid function tests in premature infants
28. Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins
29. Four radioisotopic immunoassays of free thyroxine compared
30. Underestimates of serum free thyroxine concentrations by free T4 immunoassays
31. Thyroid function testing evaluated on three immunoassay systems
32. Neonatal hypothyroidism: Treatment and outcome
33. Developmental follow-up of very low birthweight premature infants with low free thyroxine
34. Transient neonatal hypothyroxinemia and the auditory brainstem evoked response
35. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants
36. Correlates of low thyroxine values at newborn screening among infants born before 32 weeks gestation
37. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
38. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage
39. Transient hypothyroxinaemia associated with developmental delay in very preterm infants
40. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
41. Low plasma triiodothyronine concentrations and outcome in preterm infants
42. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up
43. Reduction of mortality rate in premature infants by substitution of thyroid hormones
44. Results of controlled double-blind study of thyroid replacement in very low birth weight premature infants with hypothyroxinemia
45. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants
46. L-thyroxine treatment of preterm newborns: Clinical and endocrine effects
47. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks gestation
48. Thyroid function in preterm newborns: Is T4 treatment required in infants <27 weeks gestational age?
49. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations
50. Thyroid function in very preterm newborns: Possible implications
51. Plasma thyroid hormones in premature infants: Effect of gestational age and antenatal thyrotropin-releasing hormone treatment
52. Australian collaborative trial of antenatal thyrotropin-releasing hormone: Adverse effects at 12 month follow-up